Corey J Langer

Division of Pulmonary, Allergy and Critical Care Medicine, Thoracic Oncology Group, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States; Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, United States.

View Article and Find Full Text PDF

January 2020

Clinical Outcomes of the HIV Protease Inhibitor Nelfinavir With Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer: A Phase 1/2 Trial.

Authors:

Ramesh Rengan Rosemarie Mick Daniel A Pryma Lilie Leming Lin John Christodouleas John P Plastaras Charles B Simone Anjali K Gupta Tracey L Evans James P Stevenson Corey J Langer John Kucharczuk Joseph Friedberg Sarah Lam Dana Patsch Stephen M Hahn Amit Maity

JAMA Oncol 2019 Aug 22. Epub 2019 Aug 22.

Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia.

View Article and Find Full Text PDF

August 2019

Impact of and Co-Mutations on Outcomes After First-Line Systemic Therapy Among Patients With -Mutated Advanced Non-Small-Cell Lung Cancer.

Authors:

Erin Bange Melina E Marmarelis Wei-Ting Hwang Yu-Xiao Yang Jeffrey C Thompson Jason Rosenbaum Joshua M Bauml Christine Ciunci Evan W Alley Roger B Cohen Corey J Langer Erica Carpenter Charu Aggarwal

JCO Precis Oncol 2019 10;3. Epub 2019 May 10.

University of Pennsylvania, Philadelphia, PA.

View Article and Find Full Text PDF

May 2019

Patient-reported outcomes and quality of life in advanced ALK+ non-small-cell lung cancer trial of brigatinib (ALTA).

Authors:

William R Lenderking Huamao Lin Rebecca M Speck Yanyan Zhu Hui Huang Joice Huang David Kerstein Corey J Langer

Future Oncol 2019 Aug 31;15(24):2841-2855. Epub 2019 Jul 31.

Global Outcomes Research Oncology, Millennium Pharmaceuticals, Inc., Cambridge, MA, 02139, USA, a wholly owned subsidiary of Takeda Pharmaceutical Company Ltd, Cambridge, MA, USA.

View Article and Find Full Text PDF

August 2019

Pembrolizumab After Completion of Locally Ablative Therapy for Oligometastatic Non-Small Cell Lung Cancer: A Phase 2 Trial.

Authors:

Joshua M Bauml Rosemarie Mick Christine Ciunci Charu Aggarwal Christiana Davis Tracey Evans Charuhas Deshpande Linda Miller Pooja Patel Evan Alley Christina Knepley Faith Mutale Roger B Cohen Corey J Langer

JAMA Oncol 2019 Jul 11. Epub 2019 Jul 11.

Abramson Cancer Center, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia.

View Article and Find Full Text PDF

July 2019

SWOG S1400B (NCT02785913), a Phase II Study of GDC-0032 (Taselisib) for Previously Treated PI3K-Positive Patients with Stage IV Squamous Cell Lung Cancer (Lung-MAP Sub-Study).

Authors:

Corey J Langer Mary W Redman James L Wade Charu Aggarwal Jeffrey D Bradley Jeffrey Crawford Philip J Stella Mark H Knapp Jieling Miao Katherine Minichiello Roy S Herbst Karen Kelly David R Gandara Vassiliki A Papadimitrakopoulou

J Thorac Oncol 2019 10 31;14(10):1839-1846. Epub 2019 May 31.

Thoracic/Head and Neck Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article and Find Full Text PDF

October 2019

Advanced Non-Small Cell Lung Cancer: Sequencing Agents in the EGFR-Mutated/ALK-Rearranged Populations.

Authors:

Eric K Singhi Leora Horn Lecia V Sequist John Heymach Corey J Langer

Am Soc Clin Oncol Educ Book 2019 Jan 17;39:e187-e197. Epub 2019 May 17.

4 Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article and Find Full Text PDF

January 2019

Comparative Effectiveness of Carboplatin/Pemetrexed With Versus Without Bevacizumab for Advanced Nonsquamous Non-Small Cell Lung Cancer.

Authors:

Stephen J Bagley Suzanna Talento Nandita Mitra Neal J Meropol Roger B Cohen Corey J Langer Anil Vachani

J Natl Compr Canc Netw 2019 05;17(5):469-477

Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, and.

View Article and Find Full Text PDF

May 2019

Pembrolizumab in combination with ipilimumab as second-line or later therapy for advanced non-small-cell lung cancer: KEYNOTE-021 cohorts D and H.

Authors:

Matthew A Gubens Lecia V Sequist James P Stevenson Steven F Powell Liza C Villaruz Shirish M Gadgeel Corey J Langer Amita Patnaik Hossein Borghaei Shadia I Jalal Joseph Fiore Sanatan Saraf Harry Raftopoulos Leena Gandhi

Lung Cancer 2019 04 17;130:59-66. Epub 2018 Dec 17.

Dana-Farber Cancer Institute, Boston, MA, USA; Perlmutter Cancer Center - NYU Langone Medical Center, New York, NY, USA.

View Article and Find Full Text PDF

April 2019

Influence of Mutation on Survival in Patients With Advanced -Mutant Non-Small-Cell Lung Cancer.

Authors:

Charu Aggarwal Christiana W Davis Rosemarie Mick Jeffrey C Thompson Saman Ahmed Seth Jeffries Stephen Bagley Peter Gabriel Tracey L Evans Joshua M Bauml Christine Ciunci Evan Alley Jennifer J D Morrissette Roger B Cohen Erica L Carpenter Corey J Langer

JCO Precis Oncol 2018 31;2018. Epub 2018 Aug 31.

University of Pennsylvania, Philadelphia, PA.

View Article and Find Full Text PDF

August 2018

An Economic Analysis of Radiation Therapy Oncology Group 94-10: Cost-Efficacy of Concurrent vs. Sequential Chemoradiotherapy.

Authors:

Andre Konski Mytheryi Bhargavan Jean Owen Ritsuko Komaki Corey J Langer Elizabeth Gore Rebecca Paulus Hak Choy Deborah-Watkins Bruner Walter J Curran

J Radiat Oncol 2018 Jun 10;7(2):195-201. Epub 2018 Mar 10.

Wiship Cancer Institute, Emory University, Atlanta GA.

View Article and Find Full Text PDF

June 2018

Pembrolizumab and platinum-based chemotherapy as first-line therapy for advanced non-small-cell lung cancer: Phase 1 cohorts from the KEYNOTE-021 study.

Authors:

Shirish M Gadgeel James P Stevenson Corey J Langer Leena Gandhi Hossein Borghaei Amita Patnaik Liza C Villaruz Matthew Gubens Ralph Hauke James Chih-Hsin Yang Lecia V Sequist Robert Bachman Sanatan Saraf Harry Raftopoulos Vassiliki Papadimitrakopoulou

Lung Cancer 2018 11 25;125:273-281. Epub 2018 Aug 25.

The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

November 2018

Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data.

Authors:

Joshua M Bauml Ravi Vinnakota Yeun-Hee Anna Park Susan E Bates Tito Fojo Charu Aggarwal Jessica Di Stefano Christina Knepley Sewanti Limaye Ronac Mamtani Juan Wisnivesky Nevena Damjanov Corey J Langer Roger B Cohen Keith Sigel

Cancer 2019 02 20;125(3):406-415. Epub 2018 Oct 20.

James J. Peters Veterans Affairs Medical Center, Bronx, New York.

View Article and Find Full Text PDF

February 2019

Clinical Implications of Plasma-Based Genotyping With the Delivery of Personalized Therapy in Metastatic Non-Small Cell Lung Cancer.

JAMA Oncol 2019 02;5(2):173-180

Division of Hematology-Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia.

View Article and Find Full Text PDF

February 2019

Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck.

Authors:

Joshua M Bauml Ravi Vinnakota Yeun-Hee Anna Park Susan E Bates Tito Fojo Charu Aggarwal Sewanti Limaye Nevena Damjanov Jessica Di Stefano Christine Ciunci Eric M Genden Juan P Wisnivesky Rocco Ferrandino Ronac Mamtani Corey J Langer Roger B Cohen Keith Sigel

J Natl Cancer Inst 2019 05;111(5):490-497

Department of Medicine, Division of Hematology/Oncology, James J. Peters VA Medical Center, Bronx, NY.

View Article and Find Full Text PDF

May 2019

24-Month Overall Survival from KEYNOTE-021 Cohort G: Pemetrexed and Carboplatin with or without Pembrolizumab as First-Line Therapy for Advanced Nonsquamous Non-Small Cell Lung Cancer.

Authors:

Hossein Borghaei Corey J Langer Shirish Gadgeel Vassiliki A Papadimitrakopoulou Amita Patnaik Steven F Powell Ryan D Gentzler Renato G Martins James P Stevenson Shadia I Jalal Amit Panwalkar James Chih-Hsin Yang Matthew Gubens Lecia V Sequist Mark M Awad Joseph Fiore Sanatan Saraf Steven M Keller Leena Gandhi

J Thorac Oncol 2019 01 21;14(1):124-129. Epub 2018 Aug 21.

Laura and Isaac Perlmutter Cancer Center, New York University Langone Medical Center, New York, New York.

View Article and Find Full Text PDF

January 2019

-Paclitaxel-Based Therapy in Underserved Patient Populations: The ABOUND.70+ Study in Elderly Patients With Advanced NSCLC.

Authors:

Corey J Langer Edward S Kim Eric C Anderson Robert M Jotte Manuel Modiano Daniel E Haggstrom Matei P Socoteanu David A Smith Christopher Dakhil Kartik Konduri Tymara Berry Teng J Ong Alexandra Sanford Katayoun Amiri Jonathan W Goldman Jared Weiss

Front Oncol 2018 24;8:262. Epub 2018 Jul 24.

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC, United States.

View Article and Find Full Text PDF

July 2018

Making Lung Cancer Clinical Trials More Inclusive: Recommendations for Expanding Eligibility Criteria.

Authors:

Philip Bonomi Gideon Blumenthal Andrea Stern Ferris David J Stewart Wendy K D Selig Lee M Krug Jeff Allen Gwynn Ison Corey J Langer Allen Melemed Lauretta Odogwu Upal Basu Roy Alan Sandler

J Thorac Oncol 2018 06;13(6):748-751

Genentech, San Francisco, California.

View Article and Find Full Text PDF

June 2018

Molecular and Immune Biomarker Testing in Squamous-Cell Lung Cancer: Effect of Current and Future Therapies and Technologies.

Clin Lung Cancer 2018 07 21;19(4):331-339. Epub 2018 Mar 21.

Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom.

View Article and Find Full Text PDF

July 2018

Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials.

Authors:

D Ross Camidge Dong-Wan Kim Marcello Tiseo Corey J Langer Myung-Ju Ahn Alice T Shaw Rudolf M Huber Maximilian J Hochmair Dae Ho Lee Lyudmila A Bazhenova Kathryn A Gold Sai-Hong Ignatius Ou Howard L West William Reichmann Jeff Haney Tim Clackson David Kerstein Scott N Gettinger

J Clin Oncol 2018 09 16;36(26):2693-2701. Epub 2018 May 16.

D. Ross Camidge, University of Colorado Cancer Center, Aurora, CO; Dong-Wan Kim, Seoul National University Hospital; Myung-Ju Ahn, Samsung Medical Center; Dae Ho Lee, Asan Medical Center, Seoul, South Korea; Marcello Tiseo, University Hospital of Parma, Parma, Italy; Corey J. Langer, University of Pennsylvania, Philadelphia, PA; Alice T. Shaw, Massachusetts General Hospital, Boston; William Reichmann, Jeff Haney, Tim Clackson, and David Kerstein, ARIAD Pharmaceuticals, Cambridge, MA; Rudolf M. Huber, University Hospital of Munich, Munich, Germany; Maximilian J. Hochmair, Otto Wagner Hospital, Vienna, Austria; Lyudmila A. Bazhenova and Kathryn A. Gold, University of California San Diego Moores Cancer Center, La Jolla; Sai-Hong Ignatius Ou, University of California Irvine School of Medicine, Irvine, CA; Howard L. West, Swedish Cancer Institute, Seattle, WA; and Scott N. Gettinger, Yale Cancer Center, New Haven, CT.

View Article and Find Full Text PDF

September 2018

Radiologic Pseudoprogression during Anti-PD-1 Therapy for Advanced Non-Small Cell Lung Cancer.

Authors:

Sharyn I Katz Mark Hammer Stephen J Bagley Charu Aggarwal Joshua M Bauml Jeffrey C Thompson Arun C Nachiappan Charles B Simone Corey J Langer

J Thorac Oncol 2018 07 5;13(7):978-986. Epub 2018 May 5.

Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.

View Article and Find Full Text PDF

July 2018

Osimertinib: A Novel Dermatologic Adverse Event Profile in Patients with Lung Cancer.

Authors:

Chia-Yu Chu Jennifer Choi Beth Eaby-Sandy Corey J Langer Mario E Lacouture

Oncologist 2018 08 12;23(8):891-899. Epub 2018 Apr 12.

Memorial Sloan Kettering Cancer Center, New York City, New York, USA

View Article and Find Full Text PDF

August 2018

A pooled analysis of advanced nonsquamous non-small cell lung cancer patients with stable treated brain metastases in two phase II trials receiving bevacizumab and pemetrexed as second-line therapy.

Authors:

Matthew A Gubens Jody C Chuang Wallace Akerley Corey J Langer Christelle Clément-Duchêne Melanie San Pedro-Salcedo A Dimitrios Colevas Konstantin Dragnev Mark A Socinski Heather A Wakelee

J Thorac Dis 2018 Jan;10(1):219-227

Division of Oncology, Department of Medicine, Stanford University, Stanford, CA, USA.

View Article and Find Full Text PDF

January 2018

Phase I Study of Intrapleural Gene-Mediated Cytotoxic Immunotherapy in Patients with Malignant Pleural Effusion.

Authors:

Charu Aggarwal Andrew R Haas Susan Metzger Laura K Aguilar Estuardo Aguilar-Cordova Andrea G Manzanera Gregoria Gómez-Hernández Sharyn I Katz Evan W Alley Tracey L Evans Joshua M Bauml Roger B Cohen Corey J Langer Steven M Albelda Daniel H Sterman

Mol Ther 2018 05 21;26(5):1198-1205. Epub 2018 Feb 21.

New York University Langhorne Medical Center, New York, NY 10016, USA.

View Article and Find Full Text PDF

May 2018

Current and Emergent Therapy Options for Advanced Squamous Cell Lung Cancer.

Authors:

Mark A Socinski Coleman Obasaju David Gandara Fred R Hirsch Philip Bonomi Paul A Bunn Edward S Kim Corey J Langer Ronald B Natale Silvia Novello Luis Paz-Ares Maurice Pérol Martin Reck Suresh S Ramalingam Craig H Reynolds David R Spigel Heather Wakelee Nick Thatcher

J Thorac Oncol 2018 02 23;13(2):165-183. Epub 2017 Nov 23.

The Christie Hospital, Manchester, United Kingdom.

View Article and Find Full Text PDF

February 2018

The Role of Advanced Imaging in Assessing Response to Definitive Chemoradiation Before Prophylactic Cranial Irradiation in Limited-Stage Small-Cell Lung Cancer.

Authors:

Aparna H Kesarwala Diana J Lu Eric Xanthopoulos Smith Apisarnthanarax Keith A Cengel Tracey L Evans Charu Aggarwal Roger B Cohen Corey J Langer Ramesh Rengan Charles B Simone

Clin Lung Cancer 2018 03 12;19(2):e205-e209. Epub 2017 Oct 12.

Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, MD.

View Article and Find Full Text PDF

March 2018

Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non-Small-cell Lung Cancer: Results of a Phase II Study.

Authors:

Charu Aggarwal Roger B Cohen Eddy Yu Wei-Ting Hwang Joshua M Bauml Evan Alley Tracey L Evans Corey J Langer

Clin Lung Cancer 2018 03 19;19(2):157-162. Epub 2017 Oct 19.

Hematology-Oncology Division, Department of Medicine, Perelman Center for Advanced Medicine, University of Pennsylvania, Philadelphia, PA.

View Article and Find Full Text PDF

March 2018

Emerging uses of circulating tumor DNA in advanced stage non-small cell lung cancer.

Authors:

Melina Marmarelis Jeffrey C Thompson Charu Aggarwal Tracey L Evans Erica Carpenter Roger B Cohen Corey J Langer Joshua Bauml

Ann Transl Med 2017 Sep;5(18):380

Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

View Article and Find Full Text PDF

September 2017

The Era of Checkpoint Blockade in Lung Cancer: Taking the Brakes Off the Immune System.

Authors:

Edmund K Moon Corey J Langer Steven M Albelda

Ann Am Thorac Soc 2017 Aug;14(8):1248-1260

Abramson Cancer Center, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article and Find Full Text PDF

August 2017

Caring for the Older Population With Advanced Lung Cancer.

Authors:

Carolyn J Presley Craig H Reynolds Corey J Langer

Am Soc Clin Oncol Educ Book 2017 ;37:587-596

From the VA Connecticut Cancer Center and Yale Cancer Center, West Haven and New Haven, CT; Florida Cancer Specialists and Research Institute, Ocala, FL; University of Pennsylvania Abramson Cancer Center, Philadelphia, PA.

View Article and Find Full Text PDF

November 2017

Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies.

Authors:

Corey J Langer Luis G Paz-Ares Antoinette J Wozniak Cesare Gridelli Filippo de Marinis Jean-Louis Pujol Belen San Antonio Jian Chen Jingyi Liu Ana B Oton Carla Visseren-Grul Giorgio V Scagliotti

Clin Lung Cancer 2017 09 12;18(5):489-496. Epub 2017 Apr 12.

University of Turin, Thoracic Oncology Unit, Turin, Italy. Electronic address:

View Article and Find Full Text PDF

September 2017

Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial.

J Clin Oncol 2017 Aug 5;35(22):2490-2498. Epub 2017 May 5.

Dong-Wan Kim, Seoul National University Hospital; Myung-Ju Ahn, Samsung Medical Center; Sang-We Kim, Asan Medical Center, Seoul, South Korea; Marcello Tiseo, University Hospital of Parma, Parma, Italy; Karen L. Reckamp, City of Hope, Duarte, CA; Karin Holmskov Hansen, Odense University Hospital, Odense, Denmark; Rudolf M. Huber, University Hospital of Munich, German Centre for Lung Research, Munich, Germany; Howard L. West, Swedish Cancer Institute, Seattle, WA; Harry J.M. Groen, University of Groningen, University Medical Center Groningen, Groningen; Egbert F. Smit, VU University Medical Center, Amsterdam, the Netherlands; Maximilian J. Hochmair, Otto Wagner Hospital, Vienna, Austria; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Scott N. Gettinger, Yale Cancer Center, New Haven, CT; Corey J. Langer, University of Pennsylvania Abramson Cancer Center, Philadelphia, PA; Luis G. Paz-Ares Rodríguez, Hospital Universitario 12 de Octubre, Madrid, Spain; Edward S. Kim, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC; William Reichmann, Frank G. Haluska, and David Kerstein, ARIAD Pharmaceuticals, Cambridge, MA; and D. Ross Camidge, University of Colorado Cancer Center, Aurora, CO.

View Article and Find Full Text PDF

August 2017

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer.

Authors:

Stephen J Bagley Shawn Kothari Charu Aggarwal Joshua M Bauml Evan W Alley Tracey L Evans John A Kosteva Christine A Ciunci Peter E Gabriel Jeffrey C Thompson Susan Stonehouse-Lee Victoria E Sherry Elizabeth Gilbert Beth Eaby-Sandy Faith Mutale Gloria DiLullo Roger B Cohen Anil Vachani Corey J Langer

Lung Cancer 2017 04 25;106:1-7. Epub 2017 Jan 25.

Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

View Article and Find Full Text PDF

April 2017

The Use of Antiangiogenic Agents for Lung Cancer in Elderly Patients: An Expert Panel Discussion Synopsis.

Authors:

Mark A Socinski Jamie E Chaft Benjamin Levy Gregory J Riely Corey J Langer Roman Perez-Soler Deborah L Middleton Linda Gracie-King Laura M Healy

Clin Lung Cancer 2017 05 5;18(3):255-258. Epub 2017 Jan 5.

AXIS Medical Education, Fort Lauderdale, FL.

View Article and Find Full Text PDF

May 2017

Pretreatment Red Blood Cell Total Folate Concentration Is Associated With Response to Pemetrexed in Stage IV Nonsquamous Non-Small-cell Lung Cancer.

Authors:

Stephen J Bagley Steven Vitale Suhong Zhang Charu Aggarwal Tracey L Evans Evan W Alley Roger B Cohen Corey J Langer Ian A Blair Anil Vachani Alexander S Whitehead

Clin Lung Cancer 2017 03 26;18(2):e143-e149. Epub 2016 Oct 26.

Center of Excellence in Environmental Toxicology and Center for Cancer Pharmacology, Department of Systems Pharmacology and Translational Therapeutics, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.

View Article and Find Full Text PDF

March 2017

Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial.

Authors:

Scott N Gettinger Lyudmila A Bazhenova Corey J Langer Ravi Salgia Kathryn A Gold Rafael Rosell Alice T Shaw Glen J Weiss Meera Tugnait Narayana I Narasimhan David J Dorer David Kerstein Victor M Rivera Timothy Clackson Frank G Haluska David Ross Camidge

Lancet Oncol 2016 Dec 8;17(12):1683-1696. Epub 2016 Nov 8.

University of Colorado Cancer Center, Aurora, CO, USA.

View Article and Find Full Text PDF

December 2016

Incremental Innovation and Progress in Advanced Squamous Cell Lung Cancer: Current Status and Future Impact of Treatment.

Authors:

Corey J Langer Coleman Obasaju Paul Bunn Philip Bonomi David Gandara Fred R Hirsch Edward S Kim Ronald B Natale Silvia Novello Luis Paz-Ares Maurice Pérol Martin Reck Suresh S Ramalingam Craig H Reynolds Mark A Socinski David R Spigel Heather Wakelee Carlos Mayo Nick Thatcher

J Thorac Oncol 2016 12 26;11(12):2066-2081. Epub 2016 Aug 26.

The Christie Hospital, Manchester, United Kingdom.

View Article and Find Full Text PDF

December 2016

Carboplatin and pemetrexed with or without pembrolizumab for advanced, non-squamous non-small-cell lung cancer: a randomised, phase 2 cohort of the open-label KEYNOTE-021 study.

Lancet Oncol 2016 Nov 10;17(11):1497-1508. Epub 2016 Oct 10.

Dana-Farber Cancer Institute, Boston, MA, USA; Laura and Isaac Perlmutter Cancer Center, NYU Langone Medical Center, New York, NY, USA.

View Article and Find Full Text PDF

November 2016

Scan-associated distress in lung cancer: Quantifying the impact of "scanxiety".

Authors:

Joshua M Bauml Andrea Troxel C Neill Epperson Roger B Cohen Kathryn Schmitz Carrie Stricker Lawrence N Shulman Angela Bradbury Jun J Mao Corey J Langer

Lung Cancer 2016 10 16;100:110-113. Epub 2016 Aug 16.

Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA, United States; Division of Hematology/Oncology, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, United States.

View Article and Find Full Text PDF

October 2016

Clinicopathologic Features of Advanced Squamous NSCLC.

J Thorac Oncol 2016 09 11;11(9):1411-22. Epub 2016 Jun 11.

The Christie Hospital, Manchester, United Kingdom.

View Article and Find Full Text PDF

September 2016

Acupuncture for Dyspnea in Lung Cancer: Results of a Feasibility Trial.

Authors:

Joshua Bauml Andrew Haas Charles B Simone Susan Q Li Roger B Cohen Corey J Langer Jun J Mao

Integr Cancer Ther 2016 09 24;15(3):326-32. Epub 2016 Apr 24.

Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA Department of Family Medicine and Community Health, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA.

View Article and Find Full Text PDF

September 2016

Analysis of the Relationship Between Response to Chemotherapy and Response to Radiation Therapy in Patients With Non-Small Cell Lung Cancer Receiving Sequential Treatment.

Authors:

Genevieve Maquilan Surbhi Grover Eric Xanthopoulos Tracey L Evans Charu Aggarwal Corey J Langer Roger B Cohen James P Stevenson Charles B Simone Ramesh Rengan

Am J Clin Oncol 2018 04;41(4):391-395

Perelman Center for Advanced Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA.

View Article and Find Full Text PDF

April 2018

PD-1/PD-L1 immune checkpoint blockade in non-small cell lung cancer.

Authors:

Stephen J Bagley Joshua M Bauml Corey J Langer

Clin Adv Hematol Oncol 2015 Oct;13(10):676-83

Division of Hematology/Oncology, Abramson Cancer Center and the Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article and Find Full Text PDF

October 2015

Pilot and Feasibility Trial Evaluating Immuno-Gene Therapy of Malignant Mesothelioma Using Intrapleural Delivery of Adenovirus-IFNα Combined with Chemotherapy.

Clin Cancer Res 2016 08 11;22(15):3791-800. Epub 2016 Mar 11.

Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.

View Article and Find Full Text PDF

August 2016

Do attitudes and beliefs regarding complementary and alternative medicine impact its use among patients with cancer? A cross-sectional survey.

Authors:

Joshua M Bauml Sagar Chokshi Marilyn M Schapira Eun-Ok Im Susan Q Li Corey J Langer Said A Ibrahim Jun J Mao

Cancer 2015 Jul 26;121(14):2431-8. Epub 2015 May 26.

Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article and Find Full Text PDF

July 2015

Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study.

Authors:

Eric P Xanthopoulos Elizabeth Handorf Charles B Simone Surbhi Grover Annemarie T Fernandes Sonam Sharma Michael N Corradetti Tracey L Evans Corey J Langer Nandita Mitra Anand Shah Smith Apisarnthanarax Lilie L Lin Ramesh Rengan

Pract Radiat Oncol 2015 Jul-Aug;5(4):e355-63. Epub 2015 Jan 31.

Department of Radiation Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; Currently at Department of Radiation Oncology, University of Washington School of Medicine, Seattle, Washington. Electronic address:

View Article and Find Full Text PDF

April 2016

Isolating the Role of Bevacizumab in Elderly Patients With Previously Untreated Nonsquamous Non-Small Cell Lung Cancer: Secondary Analyses of the ECOG 4599 and PointBreak Trials.

Authors:

Corey J Langer Mark A Socinski Jyoti D Patel Alan B Sandler Joan H Schiller Larry Leon Sebastien J Hazard Suresh S Ramalingam

Am J Clin Oncol 2016 10;39(5):441-7

*Abramson Cancer Center, University of Pennsylvania, Philadelphia †University of Pittsburgh Medical Center, UPMC Cancer Pavilion, Pittsburgh, PA ‡Feinberg School of Medicine, Northwestern University, Chicago, IL §Genentech Inc., South San Francisco, CA ∥Harold C. Simmons Cancer Center, University of Texas Southwestern, Dallas, TX ¶Winship Cancer Institute of Emory University, Atlanta, GA.

View Article and Find Full Text PDF

October 2016

Weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer: analysis of safety and efficacy in patients with renal impairment.

Authors:

Corey J Langer Vera Hirsh Amy Ko Markus F Renschler Mark A Socinski

Clin Lung Cancer 2015 Mar 30;16(2):112-20. Epub 2014 Sep 30.

University of Pittsburgh Medical Center, Pittsburgh, PA.

View Article and Find Full Text PDF

March 2015

Warthin's tumors and their relationship to lung cancer.

Authors:

Christine Klimowicz White Kimberly A Williams Jorge Rodriguez-Figueroa Corey J Langer

Cancer Invest 2015 Jan 4;33(1):1-5. Epub 2014 Dec 4.

Department of Medicine, Pennsylvania Hospital,1 and Perlman Center for Advanced Medicine.

View Article and Find Full Text PDF

January 2015

Phase II study of cetuximab in combination with cisplatin and radiation in unresectable, locally advanced head and neck squamous cell carcinoma: Eastern cooperative oncology group trial E3303.

Authors:

Ann Marie Egloff Ju-Whei Lee Corey J Langer Harry Quon Alec Vaezi Jennifer R Grandis Raja R Seethala Lin Wang Dong M Shin Athanassios Argiris Donghua Yang Ranee Mehra John Andrew Ridge Urjeet A Patel Barbara A Burtness Arlene A Forastiere

Clin Cancer Res 2014 Oct 8;20(19):5041-51. Epub 2014 Aug 8.

Johns Hopkins University School of Medicine and Sydney Kimmel Comprehensive Cancer Center, Baltimore, Maryland.

View Article and Find Full Text PDF

October 2014

Strategies to prevent brain metastasis in high-risk non-small-cell lung cancer: lessons learned from a randomized study of maintenance temozolomide versus observation.

Authors:

D Hunter Boggs H Ian Robins Corey J Langer Anne M Traynor Maurice J Berkowitz Minesh P Mehta

Clin Lung Cancer 2014 Nov 24;15(6):433-40. Epub 2014 Jun 24.

Department of Radiation Oncology, University of Maryland Medical Center, Baltimore, MD. Electronic address:

View Article and Find Full Text PDF

November 2014

Randomized phase II study of carboplatin and etoposide with or without obatoclax mesylate in extensive-stage small cell lung cancer.

Authors:

Corey J Langer Istvan Albert Helen J Ross Peter Kovacs L Johnetta Blakely Gabor Pajkos Attila Somfay Petr Zatloukal Andrzej Kazarnowicz Mehdi M Moezi Marshall T Schreeder Judy Schnyder Ada Ao-Baslock Ashutosh K Pathak Mark S Berger

Lung Cancer 2014 Sep 13;85(3):420-8. Epub 2014 May 13.

Gemin X Pharmaceuticals, Malvern, PA, United States.

View Article and Find Full Text PDF

September 2014

Randomized, phase III trial of first-line figitumumab in combination with paclitaxel and carboplatin versus paclitaxel and carboplatin alone in patients with advanced non-small-cell lung cancer.

Authors:

Corey J Langer Silvia Novello Keunchil Park Maciej Krzakowski Daniel D Karp Tony Mok Rebecca J Benner Judith R Scranton Anthony J Olszanski Jacek Jassem

J Clin Oncol 2014 Jul 2;32(19):2059-66. Epub 2014 Jun 2.

Corey J. Langer, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Daniel D. Karp, MD Anderson Center, Houston, TX; Rebecca J. Benner, Judith R. Scranton, Pfizer Oncology, Groton, CT; Silvia Novello, University of Turin, Orbassano, Italy; Keunchil Park, Sungkyunkwan University School of Medicine, Seoul, Korea; Maciej Krzakowski, The Maria Sklodowska-Curie Institute of Oncology, Warsaw; Jacek Jassem, Medical University of Gdansk, Gdansk, Poland; Tony Mok, Chinese University, Hong Kong, Special Administrative Region, People's Republic of China.

View Article and Find Full Text PDF

July 2014

Does perceived control predict Complementary and Alternative Medicine (CAM) use among patients with lung cancer? A cross-sectional survey.

Authors:

Joshua Bauml Corey J Langer Tracey Evans Sheila N Garland Krupali Desai Jun J Mao

Support Care Cancer 2014 Sep 9;22(9):2465-72. Epub 2014 Apr 9.

Department of Medicine, Division of Hematology/Oncology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA.

View Article and Find Full Text PDF

September 2014

Emerging immunotherapies in the treatment of non-small cell lung cancer (NSCLC): the role of immune checkpoint inhibitors.

Authors:

Corey J Langer

Am J Clin Oncol 2015 Aug;38(4):422-30

Department of Thoracic Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article and Find Full Text PDF

August 2015

Multidisciplinary therapy of stage IIIA non-small-cell lung cancer: long-term outcome of chemoradiation with or without surgery.

Authors:

Charu Aggarwal Linna Li Hossein Borghaei Ranee Mehra Neeta Somaiah Aruna Turaka Corey J Langer George R Simon

Cancer Control 2014 Jan;21(1):57-62

Department of Medicine, Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, PA 19104, USA.

View Article and Find Full Text PDF

January 2014

Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer.

Authors:

Geoffrey A Geiger Miranda B Kim Eric P Xanthopoulos Daniel A Pryma Surbhi Grover John P Plastaras Corey J Langer Charles B Simone Ramesh Rengan

Clin Lung Cancer 2014 Jan 8;15(1):79-85. Epub 2013 Oct 8.

Department of Radiation Oncology, University of Pennsylvania School of Medicine, Perelman Center for Advanced Medicine, Philadelphia, PA. Electronic address:

View Article and Find Full Text PDF

January 2014

Immunological effects of the TGFβ-blocking antibody GC1008 in malignant pleural mesothelioma patients.

Authors:

James P Stevenson Hedy L Kindler Emmanouil Papasavvas Jing Sun Mona Jacobs-Small Jennifer Hull Daniel Schwed Anjana Ranganathan Kheng Newick Daniel F Heitjan Corey J Langer John M McPherson Luis J Montaner Steven M Albelda

Oncoimmunology 2013 Aug 27;2(8):e26218. Epub 2013 Aug 27.

Penn Mesothelioma and Pleural Program; Perelman School of Medicine of the University of Pennsylvania; Philadelphia, PA USA.

View Article and Find Full Text PDF

August 2013

Epidermal growth factor receptor inhibition in mutation-positive non-small-cell lung cancer: is afatinib better or simply newer?

Authors:

Corey J Langer

J Clin Oncol 2013 Sep 26;31(27):3303-6. Epub 2013 Aug 26.

Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA.

View Article and Find Full Text PDF

September 2013

ACR appropriateness criteria nonsurgical treatment for non-small-cell lung cancer: poor performance status or palliative intent.

Authors:

Kenneth E Rosenzweig Joe Yujiao Chang Indrin J Chetty Roy H Decker Mark E Ginsburg Larry L Kestin Feng-Ming Spring Kong Brian E Lally Corey J Langer Benjamin Movsas Gregory M M Videtic Henning Willers

J Am Coll Radiol 2013 Sep 25;10(9):654-64. Epub 2013 Jul 25.

Mount Sinai School of Medicine, New York, NY, USA.

View Article and Find Full Text PDF

September 2013

Impact of PET staging in limited-stage small-cell lung cancer.

Authors:

Eric P Xanthopoulos Michael N Corradetti Nandita Mitra Annemarie T Fernandes Miranda Kim Surbhi Grover John P Christodouleas Tracey L Evans James P Stevenson Corey J Langer Tony T Lee Daniel A Pryma Lilie L Lin Charles B Simone Smith Apisarnthanarax Ramesh Rengan

J Thorac Oncol 2013 Jul;8(7):899-905

Department of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article and Find Full Text PDF

July 2013

ACR Appropriateness Criteria® radiation therapy for small-cell lung cancer.

Authors:

Feng-Ming Kong Brian E Lally Joe Yujiao Chang Indrin J Chetty Roy H Decker Mark E Ginsburg Larry L Kestin Corey J Langer Benjamin Movsas Gregory M M Videtic Henning Willers Kenneth E Rosenzweig

Am J Clin Oncol 2013 Apr;36(2):206-13

Ann Arbor Veteran Affairs Medical Center, University of Michigan, Ann Arbor, MI, USA.

View Article and Find Full Text PDF

April 2013

Cost effectiveness of personalized therapy for first-line treatment of stage IV and recurrent incurable adenocarcinoma of the lung.

Authors:

Elizabeth A Handorf Sean McElligott Anil Vachani Corey J Langer Mirar Bristol Demeter Katrina Armstrong David A Asch

J Oncol Pract 2012 Sep 19;8(5):267-74. Epub 2012 Jun 19.

University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

View Article and Find Full Text PDF

September 2012

Penetration of recommended procedures for lung cancer staging and management in the United States over 10 years: a quality research in radiation oncology survey.

Authors:

Ritsuko Komaki Najma Khalid Corey J Langer Feng-Ming Spring Kong Jean B Owen Cheryl L Crozier J Frank Wilson Xiong Wei Benjamin Movsas

Int J Radiat Oncol Biol Phys 2013 Mar 27;85(4):1082-9. Epub 2012 Dec 27.

Departmentof Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article and Find Full Text PDF

March 2013

Highlights in NSCLC from the 2012 Chicago Multidisciplinary Symposium in Thoracic Oncology.

Authors:

Corey J Langer

Clin Adv Hematol Oncol 2012 Nov;10(11 Suppl 20):1-24

Hematology-Oncology Division, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article and Find Full Text PDF

November 2012

In reply to Hastings and Iganej.

Authors:

Ramesh Gopal Kenneth E Rosenzweig Benjamin Movsas Corey J Langer

Int J Radiat Oncol Biol Phys 2012 Nov;84(3):571

View Article and Find Full Text PDF

November 2012

Targeted agents in the third-/fourth-line treatment of patients with advanced (stage III/IV) non-small cell lung cancer (NSCLC).

Authors:

Corey J Langer Tony Mok Pieter E Postmus

Cancer Treat Rev 2013 May 14;39(3):252-60. Epub 2012 Jun 14.

Hematology-Oncology Division, University of Pennsylvania, Philadelphia, PA 19104, United States.

View Article and Find Full Text PDF

May 2013

Retreatment of recurrent head and neck cancer in a previously irradiated field.

Authors:

Stuart J Wong Jean Bourhis Corey J Langer

Semin Radiat Oncol 2012 Jul;22(3):214-9

Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.

View Article and Find Full Text PDF

July 2012

Brachial plexopathy in apical non-small cell lung cancer treated with definitive radiation: dosimetric analysis and clinical implications.

Authors:

Michael J Eblan Michael N Corradetti J Nicholas Lukens Eric Xanthopoulos Nandita Mitra John P Christodouleas Surbhi Grover Annemarie T Fernandes Corey J Langer Tracey L Evans James Stevenson Ramesh Rengan Smith Apisarnthanarax

Int J Radiat Oncol Biol Phys 2013 Jan 1;85(1):175-81. Epub 2012 Jun 1.

Department of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania 19104, USA.

View Article and Find Full Text PDF

January 2013

Introduction. “small steps” in our battle with SCLC.

Authors:

Benjamin Movsas Corey J Langer

Curr Probl Cancer 2012 May-Jun;36(3):86-7

View Article and Find Full Text PDF

August 2012

Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239.

Authors:

Ritsuko Komaki Rebecca Paulus David S Ettinger Gregory M M Videtic Jeffrey D Bradley Bonnie S Glisson Corey J Langer William T Sause Walter J Curran Hak Choy

Int J Radiat Oncol Biol Phys 2012 Jul 5;83(4):e531-6. Epub 2012 May 5.

Department of Radiation Oncology, Unit 97, University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd. Houston, TX 77030, USA.

View Article and Find Full Text PDF

July 2012

Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer.

Authors:

James P Stevenson Corey J Langer Robert A Somer Tracey L Evans Kumar Rajagopalan Kimberly Krieger Mona Jacobs-Small Nikolas Dyanick Barry Milcarek Susan Coakley Suzanne Walker Beth Eaby-Sandy Alexandre Hageboutros

Cancer 2012 Nov 27;118(22):5580-7. Epub 2012 Apr 27.

Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article and Find Full Text PDF

November 2012

A phase I trial of the HIV protease inhibitor nelfinavir with concurrent chemoradiotherapy for unresectable stage IIIA/IIIB non-small cell lung cancer: a report of toxicities and clinical response.

Authors:

Ramesh Rengan Rosemarie Mick Daniel Pryma Mark A Rosen Lilie L Lin Amit M Maity Tracey L Evans James P Stevenson Corey J Langer John Kucharczuk Joseph Friedberg Susan Prendergast Tiffany Sharkoski Stephen M Hahn

J Thorac Oncol 2012 Apr;7(4):709-15

Department of Radiation Oncology, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.

View Article and Find Full Text PDF

April 2012

Older age, poor performance status and major comorbidities: how to treat high-risk patients with advanced nonsmall cell lung cancer.

Authors:

Charu Aggarwal Corey J Langer

Curr Opin Oncol 2012 Mar;24(2):130-6

Division of Hematology-Oncology, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article and Find Full Text PDF

March 2012

Exploring biomarkers in head and neck cancer.

Authors:

Corey J Langer

Cancer 2012 Aug 26;118(16):3882-92. Epub 2012 Jan 26.

Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

View Article and Find Full Text PDF

August 2012

Individualized therapy for patients with non-small cell lung cancer: emerging trends and challenges.

Authors:

Corey J Langer

Crit Rev Oncol Hematol 2012 Jul 24;83(1):130-44. Epub 2012 Jan 24.

Abramson Cancer Center, Hematology/Oncology Division, University of Pennsylvania, Philadelphia, PA, USA.

View Article and Find Full Text PDF

July 2012

Pemetrexed therapy in elderly patients with good performance status: analysis of two phase III trials of patients with nonsquamous non-small-cell lung cancer.

Authors:

Cesare Gridelli Thomas Brodowicz Corey J Langer Patrick Peterson Mominul Islam Susan C Guba Patti Moore Carla M Visseren-Grul Giorgio Scagliotti

Clin Lung Cancer 2012 Sep 23;13(5):340-6. Epub 2012 Jan 23.

Division of Medical Oncology, S.G. Moscati Hospital, Avellino, Italy.

View Article and Find Full Text PDF

September 2012

Hematologic outcomes and blood utilization in cancer patients with chemotherapy-induced anemia (CIA) pre- and post-national coverage determination (NCD): results from a multicenter chart review.

Authors:

David H Henry Corey J Langer R Scott McKenzie Catherine Tak Piech Mekré Senbetta Kathy L Schulman Edward J Stepanski

Support Care Cancer 2012 Sep 11;20(9):2089-96. Epub 2011 Dec 11.

Joan Karnell Cancer Center, Pennsylvania Hospital, Philadelphia, PA 19106, USA.

View Article and Find Full Text PDF

September 2012

ACR Appropriateness Criteria® postoperative adjuvant therapy in non-small cell lung cancer.

Authors:

Roy H Decker Corey J Langer Kenneth E Rosenzweig Joe Yujiao Chang Richard M Gewanter Mark E Ginsburg Feng-Ming Kong Brian E Lally Gregory M Videtic Benjamin Movsas

Am J Clin Oncol 2011 Oct;34(5):537-44

Yale University School of Medicine, New Haven, CT, USA.

View Article and Find Full Text PDF

October 2011

Sequential vs. concurrent chemoradiation for stage III non-small cell lung cancer: randomized phase III trial RTOG 9410.

Authors:

Walter J Curran Rebecca Paulus Corey J Langer Ritsuko Komaki Jin S Lee Stephen Hauser Benjamin Movsas Todd Wasserman Seth A Rosenthal Elizabeth Gore Mitchell Machtay William Sause James D Cox

J Natl Cancer Inst 2011 Oct 8;103(19):1452-60. Epub 2011 Sep 8.

Department of Radiation Oncology and Winship Cancer Institute, Emory University, 1365C Clifton Rd, NE, Ste C4104, Atlanta, GA 30322, USA.

View Article and Find Full Text PDF

October 2011

Roles of EGFR and KRAS Mutations in the Treatment Of Patients With Non-Small-Cell Lung Cancer.

Authors:

Corey J Langer

P T 2011 May;36(5):263-79

View Article and Find Full Text PDF

May 2011

Clinical evidence on the undertreatment of older and poor performance patients who have advanced non-small-cell lung cancer: is there a role for targeted therapy in these cohorts?

Authors:

Corey J Langer

Clin Lung Cancer 2011 Sep 11;12(5):272-9. Epub 2011 May 11.

Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.

View Article and Find Full Text PDF

September 2011

Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma.

Authors:

Girum L Lemma Ju-Whei Lee Seena C Aisner Corey J Langer William J Tester David H Johnson Patrick J Loehrer

J Clin Oncol 2011 May 18;29(15):2060-5. Epub 2011 Apr 18.

Indiana University Melvin and Bren Simon Cancer Center, Indianapolis 46202, USA.

View Article and Find Full Text PDF

May 2011

Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase.

Cancer Res 2011 Feb 10;71(3):675-85. Epub 2010 Dec 10.

Millennium Pharmaceuticals Inc., Cambridge, Massachusetts 02139, USA.

View Article and Find Full Text PDF

February 2011

The evolving role of histology in the management of advanced non-small-cell lung cancer.

Authors:

Corey J Langer Benjamin Besse Antonio Gualberto Elizabeth Brambilla Jean-Charles Soria

J Clin Oncol 2010 Dec 15;28(36):5311-20. Epub 2010 Nov 15.

Thoracic Oncology, Abramson Cancer Center, University of Pennsylvania, 3400 Civic Center Blvd, 2 Perelman Center for Advanced Medicine, Philadelphia, PA 19104, USA.

View Article and Find Full Text PDF

December 2010

ACR Appropriateness Criteria® on Induction and Adjuvant Therapy for Stage N2 Non-Small-Cell Lung Cancer: expert panel on radiation oncology-lung.

Authors:

Ramesh S Gopal Sarita Dubey Kenneth E Rosenzweig Joe Yujiao Chang Roy Decker Richard M Gewanter Feng-Ming Kong Brian E Lally Corey J Langer Hoon Ku Lee Benjamin Movsas

Int J Radiat Oncol Biol Phys 2010 Nov 31;78(4):969-74. Epub 2010 Aug 31.

University of Texas M D Anderson Cancer Center, Houston, TX, USA.

View Article and Find Full Text PDF

November 2010

Molecular analysis of non-small cell lung cancer identifies subsets with different sensitivity to insulin-like growth factor I receptor inhibition.

Authors:

Antonio Gualberto Marisa Dolled-Filhart Mark Gustavson Jason Christiansen Yu-Fen Wang Mary L Hixon Jennifer Reynolds Sandra McDonald Agnes Ang David L Rimm Corey J Langer Johnetta Blakely Linda Garland Luis G Paz-Ares Daniel D Karp Adrian V Lee

Clin Cancer Res 2010 Sep 29;16(18):4654-65. Epub 2010 Jul 29.

Department of Clinical Development and Medical Affairs, Pfizer Oncology, New London, Connecticut, USA.

View Article and Find Full Text PDF

September 2010

ACR Appropriateness Criteria: nonsurgical treatment for non-small-cell lung cancer: good performance status/definitive intent.

Authors:

Richard M Gewanter Kenneth E Rosenzweig Joe Yujiao Chang Roy Decker Sarita Dubey Feng-Ming Kong Brian E Lally Corey J Langer Hoon Ku Lee Benjamin Movsas

Curr Probl Cancer 2010 May-Jun;34(3):228-49

View Article and Find Full Text PDF

September 2010

Carboplatin/pemetrexed/bevacizumab in the treatment of patients with advanced non-small-cell lung cancer: a single-institution experience.

Authors:

Binu Malhotra Tracey Evans Jared Weiss Beth Eaby Susan Stonehouse-Lee Victoria Sherry Corey J Langer

Clin Lung Cancer 2010 May;11(3):192-7

Division of Thoracic Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA 19104 , USA.

View Article and Find Full Text PDF

May 2010

Publications by authors named "Corey J Langer"

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors:

Authors: